Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study
Phase 2
- Conditions
- Pruritus
- Registration Number
- JPRN-jRCT2080223725
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Inadequate response to current therapies
- Numerical rating scale score of 6 or more
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method